380 related articles for article (PubMed ID: 20206543)
1. Oral sildenafil for persistent pulmonary hypertension early after congenital cardiac surgery in children.
Nemoto S; Sasaki T; Ozawa H; Katsumata T; Kishi K; Okumura K; Mori Y; Umegaki O
Eur J Cardiothorac Surg; 2010 Jul; 38(1):71-7. PubMed ID: 20206543
[TBL] [Abstract][Full Text] [Related]
2. [Sildenafil in pulmonary hypertension: the opinion of pediatric cardiologist].
Micheletti A; Butera G; Chessa M; Carminati M
Pediatr Med Chir; 2008; 30(3):159-62. PubMed ID: 19024861
[No Abstract] [Full Text] [Related]
3. Use of sildenafil to facilitate weaning from inhaled nitric oxide in children with pulmonary hypertension following surgery for congenital heart disease.
Lee JE; Hillier SC; Knoderer CA
J Intensive Care Med; 2008; 23(5):329-34. PubMed ID: 18701525
[TBL] [Abstract][Full Text] [Related]
4. Impact of sildenafil therapy on pulmonary arterial hypertension in adults with congenital heart disease.
Lu XL; Xiong CM; Shan GL; Zhu XY; Wu BX; Wu GH; Liu ZH; Ni XH; Cheng XS; Gu Q; Zhao ZH; Zhang DZ; Li WM; Zhang C; Tian HY; Guo YJ; Guo T; Liu HM; Zhang WJ; Gu H; Huang SA; Chen JY; Wu WF; Huang K; Li JJ; He JG
Cardiovasc Ther; 2010 Dec; 28(6):350-5. PubMed ID: 20637015
[TBL] [Abstract][Full Text] [Related]
5. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease.
Schulze-Neick I; Hartenstein P; Li J; Stiller B; Nagdyman N; Hübler M; Butrous G; Petros A; Lange P; Redington AN
Circulation; 2003 Sep; 108 Suppl 1():II167-73. PubMed ID: 12970227
[TBL] [Abstract][Full Text] [Related]
6. Sildenafil therapy for pulmonary hypertension before and after pediatric congenital heart surgery.
Palma G; Giordano R; Russolillo V; Cioffi S; Palumbo S; Mucerino M; Poli V; Vosa C
Tex Heart Inst J; 2011; 38(3):238-42. PubMed ID: 21720460
[TBL] [Abstract][Full Text] [Related]
7. Oral sildenafil after bidirectional cavopulmonary shunt.
Soueide T; Rassi I
Ann Thorac Surg; 2008 Feb; 85(2):693-4; author reply 694-5. PubMed ID: 18222311
[No Abstract] [Full Text] [Related]
8. [Effect of sildenafil on haemodynamic parameters of pulmonary circulation and physical capacity in patients with systolic chronic heart failure with secondary severe pulmonary hypertension].
Josiak K; Inorowicz E; Petruk-Kowalczyk J; Kremis E; Wilczyński J; Zymliński R; Biegus J; Jankowska E; Banasiak W; Ponikowski P
Kardiol Pol; 2011; 69(5):517-9. PubMed ID: 21594853
[No Abstract] [Full Text] [Related]
9. Efficacy and safety of high dose generic sildenafil in Thai patients with pulmonary arterial hypertension.
Durongpisitkul K; Pornrattanarungsi S; Panjasamanvong P; Chungsomprasong P
J Med Assoc Thai; 2011 Apr; 94(4):421-6. PubMed ID: 21591526
[TBL] [Abstract][Full Text] [Related]
10. [Sildenafil in neonate pulmonary hypertension: the opinion of neonatology physician].
Condò V; Colnaghi MR; Mosca E
Pediatr Med Chir; 2008; 30(3):156-8. PubMed ID: 19024860
[No Abstract] [Full Text] [Related]
11. Bleeding after circumcision in a newborn receiving sildenafil.
Gamboa D; Robbins D; Saba Z
Clin Pediatr (Phila); 2007 Nov; 46(9):842-3. PubMed ID: 17641129
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of sildenafil in neonates and infants with congenital diaphragmatic hernia and pulmonary hypertension.
Noori S; Friedlich P; Wong P; Garingo A; Seri I
Neonatology; 2007; 91(2):92-100. PubMed ID: 17344658
[TBL] [Abstract][Full Text] [Related]
13. Sildenafil and pulmonary hypertension in children.
Prescrire Int; 2012 Jul; 21(129):178. PubMed ID: 22852281
[No Abstract] [Full Text] [Related]
14. Acute and long-term efficacy and safety of sildenafil for the treatment of chronic thromboembolic pulmonary hypertension in a heart transplant recipient.
Zacà V; Padeletti M; Pagliaro A; Furiozzi F; Mondillo S; Favilli R
Pharmacology; 2011; 87(1-2):24-7. PubMed ID: 21178386
[TBL] [Abstract][Full Text] [Related]
15. Does Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease?
Madden BP; Sheth A; Wilde M; Ong YE
Vascul Pharmacol; 2007; 47(2-3):184-8. PubMed ID: 17627899
[TBL] [Abstract][Full Text] [Related]
16. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
[TBL] [Abstract][Full Text] [Related]
17. Impact of sildenafil on survival of patients with idiopathic pulmonary arterial hypertension.
Zeng WJ; Sun YJ; Gu Q; Xiong CM; Li JJ; He JG
J Clin Pharmacol; 2012 Sep; 52(9):1357-64. PubMed ID: 21956607
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
[TBL] [Abstract][Full Text] [Related]
19. Pre-operative sildenafil and pulmonary endothelial-related complications following cardiopulmonary bypass: a randomised trial in children undergoing cardiac surgery.
Vassalos A; Peng E; Young D; Walker S; Pollock J; Macarthur K; Lyall F; Danton MH
Anaesthesia; 2011 Jun; 66(6):472-80. PubMed ID: 21457152
[TBL] [Abstract][Full Text] [Related]
20. Acute pulmonary hypertension in infants and children: cGMP-related drugs.
Fraisse A; Wessel DL
Pediatr Crit Care Med; 2010 Mar; 11(2 Suppl):S37-40. PubMed ID: 20216161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
